This activity is intended to meet the educational needs of cardiologists, EPs, and related healthcare professionals.

This on-demand webcast is available with synchronized slides and video.

Current versions of Window Media Player and Internet Explorer for your computer's operating system are recommended. Google Chrome, FireFox, Safari or other Internet browsers are not recommended as they might not interface properly with the Windows Media Player.

To be eligible for documentation of credit, participants must complete the educational activity, complete the 10-question online post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants seeking CNE or CPE credit may immediately print their documentation of credit.

TO RECEIVE PHYSICIAN CREDIT

Participants seeking physician (CME) credit may access the VHA evaluation and receive credit on the VHA website by clicking on the link provided by NACCME once you have passed the post-test on the NACCME website. You will need to pass the post-test in order to proceed to the VHA evaluation.

If you are a VHA member, you will need a vha.com username and password to register to complete the evaluation. If you do not have a vha.com username and password, click here. You may also contact VHA Customer Service at (800) 842-5146 or vhacustomerservice@vha.com to obtain assistance.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.

Release Date: December 28, 2011
Expiration Date: December 28, 2012
Estimated time to complete: 1 hour

There is no fee associated with this activity

This educational activity is a knowledge-based activity.

For questions regarding this educational activity, please call 609-371-1137.

In support of improving patient care, VHA Inc. is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.

This activity has been planned and implemented by North American Center for Continuing Medical Education, LLC (NACCME), VHA Inc. and Horizon CME for the advancement of patient care. NACCME is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

This activity is approved for 1 contact hour (0.1 CEU) of continuing pharmacy education (UAN 276-999-11-009-H01-P).

Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity accredited by NACCME may contact the Assistant Director, Accreditation Services, NACCME, in writing at 300 Rike Drive, Suite A, Millstone Township, NJ 08535. The Assistant Director, Accreditation Services will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Senior Director, Accreditation Services, NACCME, may be made for a second level of review.

Independent Clinical Reviewer: Marco Mercader, MD, George Washington University, Washington, D.C.

Nurse Reviewer: Marsha Holton, CCRN, RCIS, FSICP, Cardiovascular Orientation Programs, Indian Head, Maryland

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:

Dr. Kowey: Consultant—Astellas Pharma US, Inc., AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Johnson & Johnson, Medtronic, Inc, Merck, sanofi-aventis,U.S.; Scientific advisor—Astellas Pharma US, Inc., AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Johnson & Johnson, Medtronic, Inc, Merck, sanofi-aventis, U.S.; Promotional speakers bureau—Boehringer Ingelheim, GlaxoSmithKline, sanofi-aventis, U.S.; Stock shareholder—Cardionet
Ms. Holton has disclosed no relevant financial relationships with any commercial interest
Dr. Lee: Spouse owns a company that handles meeting management services. This company has received fees for services performed for sanofi-aventis.
Dr. Mercader: Grant/research support—George Washington University/Medical Faculty Associates Collaborative Grant, Cheney Cardiovascular Institute Grant
Dr. Naccarelli: Grant/research support—Astellas, Boehringer Ingelheim, GlaxoSmithKline; Consultant—AstraZeneca, Biocritique, Biosense Webster, Blue Ash, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Gilead, GlaxoSmithKline, Medtronic, Inc, Merck, Novartis, Ortho-McNeil-Janssen, Otsuka Pharmaceuticals, Pfizer, Portola, sanofi-aventis, U.S., St. Jude Medical, Xention
Dr. Reiffel: Grant/research support—Boehringer Ingelheim, GlaxoSmithKline; Consultant—Boehringer Ingelheim, Cardiome, Gilead, Merck, sanofi-aventis, U.S.; Scientific advisor—Boehringer Ingelheim, Cardiome, Gilead, Merck, sanofi-aventis, U.S.; Promotional speakers bureau—Boehringer Ingelheim, sanofi-aventis, U.S.

Mr. Chavez, Ms. Johnson, Dr. Naas, Ms. Ohana, Mr. Pevoto, Mr. Robbin, and Mr. Savage have disclosed no relevant financial relationships with any commercial interests.

NACCME and VHA Inc. require faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty has disclosed the following off-label/unapproved use(s) of drugs and/or devices will be discussed: amiodarone and investigational agents for the treatment of AF, and some catheters for AF ablation.